Franco, Pamela http://orcid.org/0000-0002-7954-2974
Würtemberger, Urs
Dacca, Karam
Hübschle, Irene
Beck, Jürgen
Schnell, Oliver
Mader, Irina
Binder, Harald
Urbach, Horst
Heiland, Dieter Henrik
Funding for this research was provided by:
Projekt DEAL
Article History
Received: 18 June 2020
Accepted: 15 November 2020
First Online: 23 November 2020
Ethics approval and consent to participate
: This study has been approved by the Ethics Committee of the Medical Centre University Freiburg (protocol 360/16_170908) and has been registered at the German Clinical Trials Register (DRKS) under DRKS00019855. Once participants are elected eligible, they will be required to sign two forms of informed consent: the first one for undergoing the imaging and the second one for the extraction of tumour samples for genetic analysis of residual tumour tissue after all clinically relevant investigations requiring said tumour tissue have been completed. The written informed consents will be obtained by treating neurosurgeons as well as by the neuroradiologists. Patients are informed that this study is non-interventional, meaning that they cannot expect a direct benefit from being included in the study, and that they will not undergo additional risks related to the imaging acquisition process or the tumour sample obtainment.
: Not applicable.
: The authors declare they have no competing interests.